Monday, July 26, 2021 11:01:14 PM
Comment from GreenGrowthGeek
$TFFP Is approaching a 52 week low as the last time the stock was at these levels was August 6, 2020 when the share price was on an upward rather than a downward trend. Small biotech is mostly getting hammered right now but TFFP is a Screaming Buy right now unless I am totally wrong on my DD. I added more today at this level. It could keep going down and if so I will keep adding. When the momentum turns it will turn hard and fast. Again all the momentum Quants have this as a Strong Sell right now so don't buy this stock for the short term as it could keep going down.
Recent trial news showed a Proof of Concept as the powder delivered into the lung proved to reach clinically significant blood levels at very very low doses. This is not a One Trick Pony. This technology can be used to deliver virtually any drug at much lower doses and thereby likely reduce side effects significantly. It could revive drugs that fell out of favor due to side effects and it could even revive compounds that had high efficacy but also high side effects that led to an FDA rejection. It's still very early innings on this exciting company but smart money and big Pharma are all very interested.
Jul 26, 2021.
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Recent TFFP News
- TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery • GlobeNewswire Inc. • 09/26/2024 11:00:00 AM
- TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID • GlobeNewswire Inc. • 09/11/2024 11:00:00 AM
- TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization • GlobeNewswire Inc. • 09/10/2024 11:00:00 AM
- TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:05:20 PM
- TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:01:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 12:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 09:43:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 09:42:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/14/2024 08:05:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 09:29:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/17/2024 08:07:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:05:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:04:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:03:36 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/07/2024 04:15:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 11:07:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:06:12 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/08/2023 09:52:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:10:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 10:28:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 10:26:05 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM